121 related articles for article (PubMed ID: 38569429)
1. CXCR6 defines therapeutic subtypes of CD4
Shi S; Xing H; Xu X; Chai J; Lu Z; Wang J; Wang B
Int Immunopharmacol; 2024 May; 132():111972. PubMed ID: 38569429
[TBL] [Abstract][Full Text] [Related]
2. CXCR6 Inhibits Hepatocarcinogenesis by Promoting Natural Killer T- and CD4
Mossanen JC; Kohlhepp M; Wehr A; Krenkel O; Liepelt A; Roeth AA; Möckel D; Heymann F; Lammers T; Gassler N; Hermann J; Jankowski J; Neumann UP; Luedde T; Trautwein C; Tacke F
Gastroenterology; 2019 May; 156(6):1877-1889.e4. PubMed ID: 30710528
[TBL] [Abstract][Full Text] [Related]
3. Single-cell RNA transcriptome analysis of CNS immune cells reveals CXCL16/CXCR6 as maintenance factors for tissue-resident T cells that drive synapse elimination.
Rosen SF; Soung AL; Yang W; Ai S; Kanmogne M; Davé VA; Artyomov M; Magee JA; Klein RS
Genome Med; 2022 Sep; 14(1):108. PubMed ID: 36153630
[TBL] [Abstract][Full Text] [Related]
4. Functional Heterogeneity of CD4
Oja AE; Piet B; van der Zwan D; Blaauwgeers H; Mensink M; de Kivit S; Borst J; Nolte MA; van Lier RAW; Stark R; Hombrink P
Front Immunol; 2018; 9():2654. PubMed ID: 30505306
[TBL] [Abstract][Full Text] [Related]
5. Limited HIV-2 reservoirs in central-memory CD4 T-cells associated to CXCR6 co-receptor expression in attenuated HIV-2 infection.
Samri A; Charpentier C; Diallo MS; Bertine M; Even S; Morin V; Oudin A; Parizot C; Collin G; Hosmalin A; Cheynier R; Thiébaut R; Matheron S; Collin F; Zoorob R; Brun-Vézinet F; Autran B;
PLoS Pathog; 2019 May; 15(5):e1007758. PubMed ID: 31095640
[TBL] [Abstract][Full Text] [Related]
6. CXCR6 deficiency impairs cancer vaccine efficacy and CD8
Karaki S; Blanc C; Tran T; Galy-Fauroux I; Mougel A; Dransart E; Anson M; Tanchot C; Paolini L; Gruel N; Gibault L; Lepimpec-Barhes F; Fabre E; Benhamouda N; Badoual C; Damotte D; Donnadieu E; Kobold S; Mami-Chouaib F; Golub R; Johannes L; Tartour E
J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33692218
[TBL] [Abstract][Full Text] [Related]
7. CD4
Pan Y; Wang H; An F; Wu F; Tao Q; Li Y; Ruan Y; Zhai Z
Int Immunopharmacol; 2021 Jul; 96():107742. PubMed ID: 33984717
[TBL] [Abstract][Full Text] [Related]
8. CXCR6 regulates localization of tissue-resident memory CD8 T cells to the airways.
Wein AN; McMaster SR; Takamura S; Dunbar PR; Cartwright EK; Hayward SL; McManus DT; Shimaoka T; Ueha S; Tsukui T; Masumoto T; Kurachi M; Matsushima K; Kohlmeier JE
J Exp Med; 2019 Dec; 216(12):2748-2762. PubMed ID: 31558615
[TBL] [Abstract][Full Text] [Related]
9. CXCR6 by increasing retention of memory CD8
Muthuswamy R; McGray AR; Battaglia S; He W; Miliotto A; Eppolito C; Matsuzaki J; Takemasa T; Koya R; Chodon T; Lichty BD; Shrikant P; Odunsi K
J Immunother Cancer; 2021 Oct; 9(10):. PubMed ID: 34607898
[TBL] [Abstract][Full Text] [Related]
10. CAR T-cell therapy is effective for CD19-dim B-lymphoblastic leukemia but is impacted by prior blinatumomab therapy.
Pillai V; Muralidharan K; Meng W; Bagashev A; Oldridge DA; Rosenthal J; Van Arnam J; Melenhorst JJ; Mohan D; DiNofia AM; Luo M; Cherian S; Fromm JR; Wertheim G; Thomas-Tikhonenko A; Paessler M; June CH; Luning Prak ET; Bhoj VG; Grupp SA; Maude SL; Rheingold SR
Blood Adv; 2019 Nov; 3(22):3539-3549. PubMed ID: 31738832
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxic T cells transduced with chimeric anti-CD19 receptors prevent engraftment of primary lymphoblastic leukemia in vivo.
Landmeier S; Altvater B; Pscherer S; Meltzer J; Sebire N; Pule M; Vera J; Hotfilder M; Juergens H; Vormoor J; Rossig C
Leukemia; 2010 May; 24(5):1080-4. PubMed ID: 20220773
[No Abstract] [Full Text] [Related]
12. CD4/CD8 T-Cell Selection Affects Chimeric Antigen Receptor (CAR) T-Cell Potency and Toxicity: Updated Results From a Phase I Anti-CD22 CAR T-Cell Trial.
Shah NN; Highfill SL; Shalabi H; Yates B; Jin J; Wolters PL; Ombrello A; Steinberg SM; Martin S; Delbrook C; Hoffman L; Little L; Ponduri A; Qin H; Qureshi H; Dulau-Florea A; Salem D; Wang HW; Yuan C; Stetler-Stevenson M; Panch S; Tran M; Mackall CL; Stroncek DF; Fry TJ
J Clin Oncol; 2020 Jun; 38(17):1938-1950. PubMed ID: 32286905
[TBL] [Abstract][Full Text] [Related]
13. CXCR6 is required for antitumor efficacy of intratumoral CD8
Wang B; Wang Y; Sun X; Deng G; Huang W; Wu X; Gu Y; Tian Z; Fan Z; Xu Q; Chen H; Sun Y
J Immunother Cancer; 2021 Aug; 9(8):. PubMed ID: 34462326
[TBL] [Abstract][Full Text] [Related]
14. Factors associated with treatment response to CD19 CAR-T therapy among a large cohort of B cell acute lymphoblastic leukemia.
Zhang X; Yang J; Li J; Li W; Song D; Lu XA; Wu F; Li J; Chen D; Li X; Xu Z; Liu S; Li Z; Ying K; Lu P
Cancer Immunol Immunother; 2022 Mar; 71(3):689-703. PubMed ID: 34365516
[TBL] [Abstract][Full Text] [Related]
15. CXCR6 positions cytotoxic T cells to receive critical survival signals in the tumor microenvironment.
Di Pilato M; Kfuri-Rubens R; Pruessmann JN; Ozga AJ; Messemaker M; Cadilha BL; Sivakumar R; Cianciaruso C; Warner RD; Marangoni F; Carrizosa E; Lesch S; Billingsley J; Perez-Ramos D; Zavala F; Rheinbay E; Luster AD; Gerner MY; Kobold S; Pittet MJ; Mempel TR
Cell; 2021 Aug; 184(17):4512-4530.e22. PubMed ID: 34343496
[TBL] [Abstract][Full Text] [Related]
16. Clinical grade expansion of CD45RA, CD45RO, and CD62L-positive T-cell lines from HLA-compatible donors: high cytotoxic potential against AML and ALL cells.
Barbui AM; Borleri G; Conti E; Ciocca A; Salvi A; Micò C; Introna M; Rambaldi A
Exp Hematol; 2006 Apr; 34(4):475-85. PubMed ID: 16569594
[TBL] [Abstract][Full Text] [Related]
17. Distinct Roles for CXCR6(+) and CXCR6(-) CD4(+) T Cells in the Pathogenesis of Chronic Colitis.
Mandai Y; Takahashi D; Hase K; Obata Y; Furusawa Y; Ebisawa M; Nakagawa T; Sato T; Katsuno T; Saito Y; Shimaoka T; Yokosuka O; Yokote K; Ohno H
PLoS One; 2013; 8(6):e65488. PubMed ID: 23840334
[TBL] [Abstract][Full Text] [Related]
18. Ex vivo priming for long-term maintenance of antileukemia human cytotoxic T cells suggests a general procedure for adoptive immunotherapy.
Montagna D; Maccario R; Locatelli F; Rosti V; Yang Y; Farness P; Moretta A; Comoli P; Montini E; Vitiello A
Blood; 2001 Dec; 98(12):3359-66. PubMed ID: 11719375
[TBL] [Abstract][Full Text] [Related]
19. Loss of CXCR6 coreceptor usage characterizes pathogenic lentiviruses.
Wetzel KS; Yi Y; Yadav A; Bauer AM; Bello EA; Romero DC; Bibollet-Ruche F; Hahn BH; Paiardini M; Silvestri G; Peeters M; Collman RG
PLoS Pathog; 2018 Apr; 14(4):e1007003. PubMed ID: 29659623
[TBL] [Abstract][Full Text] [Related]
20. CXCR6-Deficiency Improves the Control of Pulmonary
Ashhurst AS; Flórido M; Lin LCW; Quan D; Armitage E; Stifter SA; Stambas J; Britton WJ
Front Immunol; 2019; 10():339. PubMed ID: 30899256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
